You are here:
Melbourne Blood SpecialistsLevel 5, Suite 501 100 Victoria ParadeEast Melbourne3002
03 9654 8906
03 9654 8909
Professor Con Tam is Director of Haematology at St Vincent's Hospital, Clinical Lead for CLL and Low-Grade Lymphoma at Peter MacCallum Cancer Centre / Royal Melbourne Hospital, and Professor of Haematology at the University of Melbourne.
He has a keen interest in the biology and treatment of CLL and low-grade lymphoproliferative diseases. Prof Tam has extensive experience in the conduct of clinical trials, particularly those involving targeted therapies in B-cell malignancies.
Con is the global lead for the novel BTK inhibitor BGB-3111, and he completed the first study in the world to combine ibrutinib and venetoclax (published in New England Journal of Medicine in 2018).
Prof Tam participates actively in peer-review and is on the editorial board of Blood Advances and Leukemia & Lymphoma. Since 2012, he has received over $14 million in grants. He has authored 149 papers, for a total of 3896 Web of ScienceTM citations. He is a member of the American Society of Hematology, the American Society of Clinical Oncology, the American Association for Cancer Research, and the European Hematology Association.
Subspecialty interests include:
• CLL, lymphomas, leukemias
Download a copy of Prof Constantine Tam's profile here.